Nov 2 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 32.41 32.31 68.00
(+0.3 pct) (+6.5 pct) (+4.9 pct)
Operating 2.39 3.15 5.00
(-24.0 pct) (+48.9 pct) (+10.1 pct)
Recurring 2.53 3.08 5.00
(-17.8 pct) (+94.6 pct) (+12.7 pct)
Net 2.13 2.01 3.80
(+6.1 pct) (+24.1 pct) (+7.2 pct)
EPS 40.70 yen 37.78 yen 74.54 yen
Ann Div 32.00 yen 34.00 yen
-Q2 div 17.00 yen 16.00 yen
-Q4 div 16.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))